Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00180960|
Recruitment Status : Terminated
First Posted : September 16, 2005
Last Update Posted : September 11, 2006
The purpose of this study is to evaluate the treatment of a cancerous disease of the peritoneum with complete cytoreductive surgery with intraperitoneal chemohyperthermia using oxaliplatin plus irinotecan.
This is a Phase II study with 100 patients. Origins of the tumors: these include colon, rectum, appendix, peritoneum, and endocrine tumors.
|Condition or disease||Intervention/treatment||Phase|
|Colon Tumors Rectum Tumors Appendix Tumors Peritoneum Tumors Endocrine Tumors||Drug: Oxaliplatin and irinotecan||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery With Intraperitoneal Chemohyperthermia Using Oxaliplatin Plus Irinotecan|
|Study Start Date :||June 2003|
- To study overall survival
- To study mortality-morbidity
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00180960
|Villejuif, France, 94800|
|Principal Investigator:||Dominique Elias, MD||Gustave Roussy, Cancer Campus, Grand Paris|